Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 36 | 2022 | 5696 | 2.840 |
Why?
|
Sentinel Lymph Node Biopsy | 12 | 2021 | 732 | 2.250 |
Why?
|
Skin Neoplasms | 31 | 2021 | 5811 | 2.110 |
Why?
|
Lymph Node Excision | 12 | 2021 | 1269 | 1.150 |
Why?
|
Lymph Nodes | 8 | 2019 | 3461 | 1.110 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 7 | 2020 | 94 | 0.950 |
Why?
|
Lymphatic Metastasis | 15 | 2019 | 2913 | 0.680 |
Why?
|
Inguinal Canal | 1 | 2019 | 71 | 0.670 |
Why?
|
Leiomyosarcoma | 2 | 2020 | 422 | 0.640 |
Why?
|
Ilium | 1 | 2019 | 154 | 0.630 |
Why?
|
Retroperitoneal Neoplasms | 2 | 2024 | 333 | 0.630 |
Why?
|
Radiotherapy, Adjuvant | 6 | 2020 | 1784 | 0.550 |
Why?
|
Australia | 12 | 2021 | 1249 | 0.500 |
Why?
|
Neoplasm Recurrence, Local | 12 | 2020 | 9277 | 0.500 |
Why?
|
Neoplasms, Second Primary | 2 | 2022 | 1051 | 0.480 |
Why?
|
Breast Neoplasms | 23 | 2020 | 20988 | 0.440 |
Why?
|
Preoperative Care | 2 | 2024 | 2242 | 0.430 |
Why?
|
Neoplasm Staging | 19 | 2021 | 11118 | 0.390 |
Why?
|
Acetone | 1 | 2011 | 44 | 0.380 |
Why?
|
Head and Neck Neoplasms | 4 | 2020 | 2894 | 0.380 |
Why?
|
Methanol | 1 | 2011 | 92 | 0.370 |
Why?
|
Melanocytes | 1 | 2014 | 509 | 0.370 |
Why?
|
Sarcoma | 2 | 2024 | 1800 | 0.370 |
Why?
|
Groin | 1 | 2011 | 106 | 0.370 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1639 | 0.360 |
Why?
|
Mammography | 5 | 2018 | 2430 | 0.350 |
Why?
|
Quality of Life | 4 | 2019 | 13359 | 0.340 |
Why?
|
Melphalan | 6 | 2020 | 420 | 0.310 |
Why?
|
Titanium | 1 | 2011 | 485 | 0.310 |
Why?
|
Soft Tissue Neoplasms | 1 | 2017 | 1158 | 0.310 |
Why?
|
Skin | 3 | 2020 | 4472 | 0.310 |
Why?
|
Precancerous Conditions | 1 | 2014 | 982 | 0.290 |
Why?
|
Surgical Flaps | 2 | 2018 | 1670 | 0.280 |
Why?
|
Prognosis | 18 | 2024 | 29601 | 0.280 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 876 | 0.280 |
Why?
|
Patient Care | 1 | 2012 | 621 | 0.260 |
Why?
|
Survival Rate | 9 | 2020 | 12719 | 0.250 |
Why?
|
Risk Assessment | 5 | 2016 | 23974 | 0.250 |
Why?
|
Breast | 4 | 2018 | 1963 | 0.250 |
Why?
|
Extremities | 3 | 2020 | 867 | 0.240 |
Why?
|
Water | 1 | 2011 | 1409 | 0.240 |
Why?
|
Immunologic Factors | 1 | 2014 | 1589 | 0.240 |
Why?
|
Neoplastic Stem Cells | 2 | 2016 | 1350 | 0.240 |
Why?
|
Neoplasm Invasiveness | 10 | 2019 | 3593 | 0.240 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2006 | 327 | 0.230 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2812 | 0.230 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2020 | 549 | 0.230 |
Why?
|
Carcinoma in Situ | 2 | 2006 | 791 | 0.220 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39062 | 0.200 |
Why?
|
Lower Extremity | 4 | 2020 | 1200 | 0.200 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2006 | 1084 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2020 | 11735 | 0.200 |
Why?
|
Aged, 80 and over | 22 | 2020 | 58919 | 0.190 |
Why?
|
Lymphedema | 2 | 2019 | 523 | 0.190 |
Why?
|
Mastectomy | 2 | 2006 | 1817 | 0.190 |
Why?
|
Radiotherapy | 2 | 2020 | 1497 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5672 | 0.190 |
Why?
|
Humans | 69 | 2024 | 760740 | 0.180 |
Why?
|
Aged | 32 | 2024 | 169092 | 0.180 |
Why?
|
Middle Aged | 38 | 2024 | 220603 | 0.180 |
Why?
|
Upper Extremity | 3 | 2020 | 658 | 0.170 |
Why?
|
Subcutaneous Tissue | 1 | 2020 | 132 | 0.170 |
Why?
|
Female | 50 | 2024 | 392203 | 0.170 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7390 | 0.170 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2057 | 0.160 |
Why?
|
Dactinomycin | 4 | 2020 | 304 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 4 | 2018 | 6473 | 0.150 |
Why?
|
Propranolol | 1 | 2019 | 490 | 0.150 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13383 | 0.150 |
Why?
|
Indoles | 2 | 2017 | 1830 | 0.150 |
Why?
|
Biopsy, Fine-Needle | 2 | 2020 | 1118 | 0.150 |
Why?
|
Neoplasm Metastasis | 7 | 2020 | 4910 | 0.150 |
Why?
|
Mammary Glands, Human | 2 | 2016 | 202 | 0.140 |
Why?
|
Phlebotomy | 1 | 2018 | 137 | 0.140 |
Why?
|
Adult | 31 | 2024 | 220995 | 0.140 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2019 | 617 | 0.140 |
Why?
|
Stromal Cells | 2 | 2015 | 1329 | 0.140 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2017 | 943 | 0.140 |
Why?
|
Manikins | 1 | 2018 | 244 | 0.140 |
Why?
|
Punctures | 1 | 2018 | 364 | 0.130 |
Why?
|
Quality Improvement | 1 | 2012 | 3801 | 0.130 |
Why?
|
Collagenases | 1 | 2016 | 222 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13635 | 0.130 |
Why?
|
Male | 29 | 2024 | 360402 | 0.130 |
Why?
|
Rose Bengal | 1 | 2016 | 115 | 0.130 |
Why?
|
Epithelium | 3 | 2018 | 1603 | 0.130 |
Why?
|
Scalp | 1 | 2018 | 389 | 0.120 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2016 | 198 | 0.120 |
Why?
|
Retrospective Studies | 14 | 2022 | 80583 | 0.120 |
Why?
|
Immunohistochemistry | 8 | 2021 | 11069 | 0.120 |
Why?
|
Liposarcoma | 1 | 2017 | 289 | 0.120 |
Why?
|
Disease Management | 3 | 2021 | 2506 | 0.120 |
Why?
|
Hydroxamic Acids | 1 | 2017 | 481 | 0.110 |
Why?
|
Morbidity | 1 | 2019 | 1750 | 0.110 |
Why?
|
Necrosis | 1 | 2018 | 1610 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 4569 | 0.110 |
Why?
|
Neck Dissection | 1 | 2014 | 201 | 0.100 |
Why?
|
Skin Transplantation | 1 | 2018 | 1083 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 2821 | 0.100 |
Why?
|
Axilla | 3 | 2010 | 624 | 0.100 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 774 | 0.100 |
Why?
|
Pilot Projects | 3 | 2024 | 8619 | 0.100 |
Why?
|
Survival Analysis | 6 | 2020 | 10072 | 0.100 |
Why?
|
Prospective Studies | 10 | 2019 | 54364 | 0.100 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 928 | 0.100 |
Why?
|
Hospital Information Systems | 1 | 2013 | 394 | 0.090 |
Why?
|
Adsorption | 1 | 2011 | 197 | 0.090 |
Why?
|
New Zealand | 1 | 2012 | 358 | 0.090 |
Why?
|
Monosaccharide Transport Proteins | 2 | 2003 | 436 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2024 | 4058 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12966 | 0.090 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6807 | 0.090 |
Why?
|
Organoids | 1 | 2016 | 744 | 0.090 |
Why?
|
Immunomodulation | 1 | 2014 | 548 | 0.090 |
Why?
|
Carcinoma, Ductal | 1 | 2010 | 97 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2018 | 5239 | 0.080 |
Why?
|
Biopsy | 2 | 2019 | 6763 | 0.080 |
Why?
|
Medical Order Entry Systems | 1 | 2013 | 521 | 0.080 |
Why?
|
Receptor, erbB-2 | 2 | 2017 | 2553 | 0.080 |
Why?
|
Surface Properties | 1 | 2011 | 1162 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1901 | 0.080 |
Why?
|
Immunotherapy | 2 | 2019 | 4642 | 0.070 |
Why?
|
Dermatology | 1 | 2018 | 918 | 0.070 |
Why?
|
Watchful Waiting | 1 | 2012 | 491 | 0.070 |
Why?
|
Medication Errors | 1 | 2013 | 783 | 0.070 |
Why?
|
Caveolin 1 | 1 | 2009 | 255 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3683 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2332 | 0.070 |
Why?
|
Collagen | 1 | 2015 | 2634 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1865 | 0.070 |
Why?
|
Carcinoma, Lobular | 1 | 2010 | 480 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2017 | 2827 | 0.070 |
Why?
|
Phenotype | 3 | 2019 | 16572 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2373 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1977 | 0.060 |
Why?
|
Mastectomy, Segmental | 1 | 2010 | 955 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2022 | 22153 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18381 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2017 | 3045 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2020 | 64572 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4021 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2007 | 748 | 0.060 |
Why?
|
RNA, Neoplasm | 2 | 2004 | 749 | 0.060 |
Why?
|
Guidelines as Topic | 2 | 2021 | 1386 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4408 | 0.050 |
Why?
|
Recurrence | 1 | 2015 | 8426 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2004 | 315 | 0.050 |
Why?
|
Length of Stay | 2 | 2020 | 6418 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2004 | 453 | 0.050 |
Why?
|
Young Adult | 7 | 2020 | 59191 | 0.050 |
Why?
|
Risk Factors | 5 | 2019 | 74128 | 0.050 |
Why?
|
Cell Division | 2 | 2007 | 4457 | 0.050 |
Why?
|
Gene Dosage | 2 | 2004 | 1217 | 0.050 |
Why?
|
Tumor Cells, Cultured | 5 | 2016 | 6126 | 0.050 |
Why?
|
Cohort Studies | 7 | 2020 | 41464 | 0.050 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2003 | 418 | 0.050 |
Why?
|
Mice, SCID | 2 | 2016 | 2625 | 0.050 |
Why?
|
RNA, Messenger | 5 | 2016 | 12759 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20556 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2004 | 901 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2004 | 1056 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2004 | 1386 | 0.040 |
Why?
|
Tourniquets | 1 | 2020 | 107 | 0.040 |
Why?
|
Receptors, Estrogen | 2 | 2009 | 2208 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10759 | 0.040 |
Why?
|
Urban Population | 1 | 2006 | 2034 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 242 | 0.040 |
Why?
|
Creatine Kinase | 1 | 2020 | 685 | 0.040 |
Why?
|
National Health Programs | 1 | 2021 | 440 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2017 | 3599 | 0.040 |
Why?
|
Incidence | 2 | 2014 | 21339 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 3776 | 0.040 |
Why?
|
Mass Screening | 2 | 2019 | 5425 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9171 | 0.040 |
Why?
|
Extracorporeal Circulation | 1 | 2017 | 181 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2017 | 10429 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2002 | 1152 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10507 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2013 | 4810 | 0.030 |
Why?
|
Rural Population | 1 | 2006 | 2277 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15609 | 0.030 |
Why?
|
Skin Ulcer | 1 | 2017 | 130 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2016 | 280 | 0.030 |
Why?
|
Estrogens | 1 | 2002 | 1521 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 678 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 1008 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 777 | 0.030 |
Why?
|
Estradiol | 1 | 2002 | 1937 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3514 | 0.030 |
Why?
|
Glycoproteins | 1 | 2002 | 2200 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1892 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2020 | 1263 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2006 | 2527 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2018 | 797 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4110 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2391 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2016 | 422 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1756 | 0.030 |
Why?
|
Glucose Transport Proteins, Facilitative | 2 | 2003 | 57 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2017 | 356 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1113 | 0.030 |
Why?
|
Queensland | 1 | 2012 | 52 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10754 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1496 | 0.020 |
Why?
|
Macrophages | 2 | 2018 | 5758 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1827 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2018 | 1149 | 0.020 |
Why?
|
Mitosis | 1 | 2017 | 1187 | 0.020 |
Why?
|
Ischemia | 1 | 2020 | 1885 | 0.020 |
Why?
|
Blood Vessels | 1 | 2017 | 1112 | 0.020 |
Why?
|
United States | 4 | 2020 | 72292 | 0.020 |
Why?
|
Animals | 6 | 2017 | 168202 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2015 | 1864 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 737 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2017 | 16968 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1380 | 0.020 |
Why?
|
Mice | 5 | 2017 | 81368 | 0.020 |
Why?
|
Immunosorbent Techniques | 1 | 2009 | 174 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2010 | 510 | 0.020 |
Why?
|
Trust | 1 | 2013 | 529 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5034 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1575 | 0.020 |
Why?
|
Commerce | 1 | 2013 | 608 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2456 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2017 | 2191 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2004 | 2509 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42193 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2018 | 2722 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15250 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9417 | 0.020 |
Why?
|
Victoria | 1 | 2006 | 64 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5780 | 0.020 |
Why?
|
Medical Informatics | 1 | 2013 | 732 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2925 | 0.020 |
Why?
|
Child | 3 | 2020 | 80089 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10549 | 0.020 |
Why?
|
Magnetics | 1 | 2009 | 597 | 0.020 |
Why?
|
Microspheres | 1 | 2009 | 782 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5863 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4570 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2009 | 639 | 0.020 |
Why?
|
Mutation | 2 | 2021 | 30015 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7995 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 88247 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 39908 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4745 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2017 | 2238 | 0.010 |
Why?
|
Data Collection | 1 | 2013 | 3316 | 0.010 |
Why?
|
Integrin-Binding Sialoprotein | 1 | 2004 | 23 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 2009 | 1129 | 0.010 |
Why?
|
Cell Separation | 1 | 2009 | 1718 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8998 | 0.010 |
Why?
|
Paraffin Embedding | 1 | 2003 | 302 | 0.010 |
Why?
|
Sequence Homology | 1 | 2002 | 196 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2002 | 240 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2003 | 1301 | 0.010 |
Why?
|
Continuity of Patient Care | 1 | 2007 | 1067 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 1545 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9476 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20077 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2004 | 2010 | 0.010 |
Why?
|
Neck | 1 | 2004 | 734 | 0.010 |
Why?
|
Introns | 1 | 2002 | 968 | 0.010 |
Why?
|
Gene Library | 1 | 2002 | 1055 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1624 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1646 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12043 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1989 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 2089 | 0.010 |
Why?
|
Gene Amplification | 1 | 2003 | 1087 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2002 | 960 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36157 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26065 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2002 | 2467 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18220 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12448 | 0.010 |
Why?
|
Mice, Nude | 1 | 2004 | 3606 | 0.010 |
Why?
|
Models, Animal | 1 | 2004 | 2108 | 0.010 |
Why?
|
Oncogenes | 1 | 2003 | 1220 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1964 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4919 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9526 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 4172 | 0.010 |
Why?
|
Menopause | 1 | 2004 | 1645 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 1670 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2381 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5765 | 0.010 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2003 | 926 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6188 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2009 | 3196 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2002 | 1650 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2003 | 4611 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6520 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6074 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23415 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14388 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 3680 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2803 | 0.010 |
Why?
|
Registries | 1 | 2007 | 8209 | 0.010 |
Why?
|
Glucose | 1 | 2003 | 4345 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13442 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17630 | 0.010 |
Why?
|
Insulin | 1 | 2002 | 6593 | 0.000 |
Why?
|
Proteins | 1 | 2002 | 6030 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2003 | 8542 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2002 | 26183 | 0.000 |
Why?
|
Pregnancy | 1 | 2002 | 29869 | 0.000 |
Why?
|